These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38279671)

  • 21. Effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia.
    Pickar D; Bartko JJ
    Am J Psychiatry; 2003 Jun; 160(6):1133-8. PubMed ID: 12777272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the ITIH3 rs2535629 variant in antipsychotic response.
    Brandl EJ; Lett TA; Chowdhury NI; Tiwari AK; Bakanidze G; Meltzer HY; Potkin SG; Lieberman JA; Kennedy JL; Müller DJ
    Schizophr Res; 2016 Oct; 176(2-3):131-135. PubMed ID: 27396837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study.
    Petrides G; Malur C; Braga RJ; Bailine SH; Schooler NR; Malhotra AK; Kane JM; Sanghani S; Goldberg TE; John M; Mendelowitz A
    Am J Psychiatry; 2015 Jan; 172(1):52-8. PubMed ID: 25157964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia.
    Kelly DL; Feldman S; Boggs DL; Gale E; Conley RR
    Compr Psychiatry; 2010; 51(3):298-302. PubMed ID: 20399340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship of antipsychotic treatment with reduced brown adipose tissue activity in patients with schizophrenia.
    Chen PY; Chiu CC; Hsieh TH; Liu YR; Chen CH; Huang CY; Lu ML; Huang MC
    Psychoneuroendocrinology; 2022 Aug; 142():105775. PubMed ID: 35594830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial.
    Chang JS; Ahn YM; Park HJ; Lee KY; Kim SH; Kang UG; Kim YS
    J Clin Psychiatry; 2008 May; 69(5):720-31. PubMed ID: 18370574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple serum anti-glutamate receptor antibody levels in clozapine-treated/naïve patients with treatment-resistant schizophrenia.
    He J; Li J; Wei Y; He Z; Liu J; Yuan N; Zhou R; He X; Ren H; Gu L; Liao Y; Chen X; Tang J
    BMC Psychiatry; 2024 Apr; 24(1):248. PubMed ID: 38566016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study.
    Genç Y; Taner E; Candansayar S
    Adv Ther; 2007; 24(1):1-13. PubMed ID: 17526456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
    Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
    Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study.
    Dursun SM; Szemis A; Andrews H; Reveley MA
    J Psychiatry Neurosci; 1999 Nov; 24(5):453-5. PubMed ID: 10586536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia.
    Lee MA; Cola P; Jayathilake K; Meltzer HY
    J Clin Psychopharmacol; 2023 May-Jun 01; 43(3):211-219. PubMed ID: 36975722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study.
    Veerman SR; Schulte PF; Smith JD; de Haan L
    Psychol Med; 2016 Jul; 46(9):1909-21. PubMed ID: 27048954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study.
    Dursun SM; Szemis A; Andrews H; Whitaker P; Reveley MA
    J Psychiatry Neurosci; 2000 Sep; 25(4):347-52. PubMed ID: 11022399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis.
    Mizuno Y; McCutcheon RA; Brugger SP; Howes OD
    Neuropsychopharmacology; 2020 Mar; 45(4):622-631. PubMed ID: 31766049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.
    Woodward ND; Jayathilake K; Meltzer HY
    Schizophr Res; 2007 Feb; 90(1-3):86-96. PubMed ID: 17123785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study.
    Yasui-Furukori N; Muraoka H; Hasegawa N; Ochi S; Numata S; Hori H; Hishimoto A; Onitsuka T; Ohi K; Hashimoto N; Nagasawa T; Takaesu Y; Inagaki T; Tagata H; Tsuboi T; Kubota C; Furihata R; Iga JI; Iida H; Miura K; Matsumoto J; Yamada H; Watanabe K; Inada K; Shimoda K; Hashimoto R
    Neuropsychopharmacol Rep; 2022 Mar; 42(1):3-9. PubMed ID: 34854260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment.
    Kaneda Y; Jayathilak K; Meltzer H
    Psychiatry Res; 2010 Jun; 178(1):57-62. PubMed ID: 20452677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Acute Followed by Maintenance ECT vs Clozapine on Psychopathology and Regional Cerebral Blood Flow in Treatment-Resistant Schizophrenia: A Randomized Controlled Trial.
    Mishra BR; Agrawal K; Biswas T; Mohapatra D; Nath S; Maiti R
    Schizophr Bull; 2022 Jun; 48(4):814-825. PubMed ID: 35556138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Clozapine Delay on Clinical Outcomes in Schizophrenia.
    Law C; See YM; Yee JY; Ng BT; Tang C; Lee J
    J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37616477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.